查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
先进癌症诊断市场，按类型、按应用、按最终用途、按国家和地区划分 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1388767

先进癌症诊断市场，按类型、按应用、按最终用途、按国家和地区划分 - 2023-2030 年行业分析、市场规模、市场份额和预测

Advanced Cancer Diagnostics Market, By Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，先进癌症诊断市场规模为 23,000.07 百万美元，2023 年至 2030 年复合CAGR为 13.2%。

先进的癌症诊断利用尖端技术和技术来准确识别和诊断癌症。这些诊断对于改善患者治疗效果、根据个人需求量身定制治疗以及优化癌症管理至关重要。随着免疫疗法和标靶治疗等创新疗法的引入，先进癌症治疗领域取得了重大进展。此外，化疗、放疗、手术等传统治疗方法也加强。例如，次世代定序 (NGS) 和其他基因组分析技术可以分析癌症患者的 DNA、RNA 和蛋白质谱，有助于识别特定的基因突变，从而为治疗决策和预后提供资讯。

先进癌症诊断市场-市场动态

全球癌症发生率的上升推动了市场的成长

由于生活方式的改变、环境因素和人口老化等多种因素，全球癌症发生率一直在上升。随着癌症病例的增加，对先进诊断技术的需求日益增长。世界卫生组织报告称，癌症是全球主要死亡原因，2020 年将导致近 1,000 万人死亡，约占死亡人数的六分之一。根据人口成长和老化预测，到 2040 年，全球癌症负担预计将增加 60% 以上，预计当年新增病例将达到 2,940 万，而 2018 年为 1,810 万。此外，预计市场成长机会研发投入和技术进步推动。然而，新兴经济体缺乏认识限制了市场的成长。

先进癌症诊断市场 - 关键见解

  • 根据我们的研究分析师分享的分析，预计全球高级癌症诊断市场在预测期内（2023-2030 年）每年将以 13.2% 左右的CAGR增长
  • 由于全球癌症病例盛行率不断上升，预计先进癌症诊断产业将以显着的速度成长。
  • 根据类型细分，预计下一代定序将在 2022 年显示最大的市场份额
  • 根据应用细分，乳癌细分市场是 2022 年的主导类型
  • 根据最终用户细分，医院产业是 2022 年的领先类型
  • 按地区划分，北美是 2022 年的主要收入来源

先进癌症诊断市场-細項分析：

全球先进癌症诊断市场根据类型、应用、最终用户和地区进行细分。

市场根据类型分为六类：新一代定序、晶片实验室、细胞分析、即时 PCR (RT_PCR)、多重阵列和高密度微阵列。新一代定序主导市场。癌症发病率的上升、对诊断准确性提高的要求以及特定标靶疗法的进步推动了下一代定序的激增。

根据应用，市场分为十二类：乳癌、子宫颈癌、大肠癌、摄护腺癌、肺癌、皮肤癌、血液癌、肝癌、肾癌、卵巢癌、胰臟癌等。该市场在很大程度上受到乳癌细分市场的影响，该细分市场受到多种因素的推动，包括乳癌病例的增加、技术的进步以及对早期检测重要性的高度认识。

根据最终用户，市场分为三类：医院、门诊手术中心、诊断实验室和其他。由于癌症发病率上升、对先进诊断工具的需求增加以及对早期和精确癌症检测和管理的日益重视，医院主导了市场。

先进癌症诊断市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。预计北美市场的成长将主要受到政府和私人实体对癌症诊断的资金和投资的快速涌入的主导。包括美国和加拿大在内的北美各国政府已发起各种措施来支持癌症研究和诊断。此外，製药公司、诊断公司和创投公司正在癌症诊断和相关技术方面进行大量投资。这些投资旨在支持创新诊断工具和疗法的开发。根据国际癌症研究合作组织（ICR Partners）2021年的一项研究，2018年研究投资已增加至85.11亿美元。值得注意的是，ICR合作伙伴仅占全球癌症资助机构的一小部分。另一项研究确定了 4693 个提供癌症研究经费的组织，其中近一半被列为非营利组织，只有 12% 被列为政府组织。预计欧洲和亚太地区将在预测期内推动市场的成长。

先进癌症诊断市场-竞争格局：

先进的癌症诊断市场的特点是其动态性，受到不断的技术进步和不断变化的医疗保健需求的推动。为了在这个快速发展的市场中保持竞争地位，公司必须优先考虑创新、策略合作伙伴关係和全球扩张。该行业的领先公司正在引入先进的测试和诊断，以满足对改进诊断解决方案不断增长的需求。专门从事血癌诊断的製造商正在重点关注 Type 的推出并实施新的诊断方法来优化其测试流程。此外，他们正在采用最新的技术和创新，确保遵守标准政策以加快审批流程。早期检测领域有许多关键参与者，从 Grail、Guardant 和 Exact Sciences 等大公司到 Freenome 和 Singlera 等有前景的新创公司。这些公司因其突破性的公告和成就而获得了极大的兴趣和资金。值得注意的是，他们的贡献包括大规模研究、多功能机器学习/人工智慧演算法、泛癌症检测测试以及数百美元的大量资金。这些公司中的每家都拥有独特的竞争优势，使其在市场上脱颖而出。

最近的发展：

2022 年 6 月 29 日 - 罗氏最新精密组织染色平台 BenchMark ULTRA PLUS 结构推出。该系统提供快速、可靠的测试结果，使医生能够及时选择患者的治疗路径。

目录

第 1 章：先进癌症诊断市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的先进癌症诊断市场片段
    • 先进癌症诊断市场片段（按应用）
    • 最终用户的先进癌症诊断市场片段
    • 按国家/地区分類的先进癌症诊断市场片段
    • 按地区分類的先进癌症诊断市场片段
  • 竞争洞察

第 3 章：先进癌症诊断主要市场趋势

  • 先进癌症诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 先进癌症诊断市场限制
    • 市场限制影响分析
  • 先进的癌症诊断市场机会
  • 先进癌症诊断市场未来趋势

第 4 章：先进癌症诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：先进癌症诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：先进癌症诊断市场格局

  • 2022 年先进癌症诊断市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：先进癌症诊断市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 下一代定序
    • 晶片实验室
    • 细胞分析
    • 即时萤光定量PCR (RT_PCR)
    • 多路復用阵列
    • 高密度微阵列

第 8 章：先进癌症诊断市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 胸部
    • 子宫颈
    • 大肠直肠
    • 摄护腺
    • 肺
    • 皮肤
    • 血
    • 肝
    • 肾
    • 卵巢
    • 胰腺癌
    • 其他的

第 9 章：先进癌症诊断市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 门诊手术中心
    • 诊断实验室
    • 其他的

第 10 章：先进癌症诊断市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美先进癌症诊断主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲先进癌症诊断主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区先进癌症诊断主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲先进癌症诊断主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲先进癌症诊断主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 先进癌症诊断产业

  • 竞争仪表板
  • 公司简介
    • Roche Diagnostics
    • Abbott Laboratories
    • Biocept
    • Beckman Coulter Inc
    • Becton Dickinson and Co.
    • Affymetrix Inc
    • Biotheranostics
    • GE Healthcare
    • Gen-Probe Inc
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1828

REPORT HIGHLIGHT

Advanced Cancer Diagnostics Market size was valued at USD 23,000.07 Million in 2022, expanding at a CAGR of 13.2% from 2023 to 2030.

Advanced cancer diagnostics utilizes cutting-edge techniques and technologies to accurately identify and diagnose cancer. These diagnostics are crucial in improving patient outcomes, tailoring treatments to individual needs, and optimizing cancer management. The field of advanced cancer treatment has seen significant progress, with the introduction of innovative therapies like immunotherapy and targeted treatments. Additionally, traditional treatment methods such as chemotherapy, radiation, and surgery have also been enhanced. For example, Next-generation sequencing (NGS) and other genomic profiling techniques enable the analysis of a cancer patient's DNA, RNA, and protein profiles, facilitating the identification of specific genetic mutations that inform treatment decisions and prognosis.

Advanced Cancer Diagnostics Market- Market Dynamics

The rising prevalence of cancer cases globally propels the growth of the market

The incidence of cancer has been increasing globally due to a multitude of factors such as changes in lifestyle, environmental factors, and an aging population. With the rise in cancer cases, there is a growing need for advanced diagnostic techniques. The World Health Organization reports that cancer is a leading cause of death worldwide, responsible for almost 10 million deaths in 2020, which is approximately one in six deaths. Based on population growth and aging projections, the global burden of cancer is expected to increase by over 60% by 2040, with a predicted 29.4 million new cases in that year compared to 18.1 million in 2018. Additionally, the market growth opportunity is expected to be propelled by R&D investment and technological advancement. Nevertheless, the lack of awareness in emerging economies poses a limitation to the growth of the market.

Advanced Cancer Diagnostics Market- Key Insights

  • As per the analysis shared by our research analyst, the global Advanced Cancer Diagnostics market is estimated to grow annually at a CAGR of around 13.2% over the forecast period (2023-2030)
  • The Advanced Cancer Diagnostics industry is projected to grow at a significant rate due to the rising prevalence of cancer cases globally.
  • Based on Type segmentation, Next-generation sequencing was predicted to show maximum market share in the year 2022
  • Based on Application segmentation, the breast cancer segment was the leading type in 2022
  • Based on End-User segmentation, Hospitals sector was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Advanced Cancer Diagnostics Market- Segmentation Analysis:

The Global Advanced Cancer Diagnostics Market is segmented on the basis of Type, Application, End-User, and Region.

The market is divided into six categories based on Type: Next-generation sequencing, Lab-on-a-chip, Cellular analysis, Real-time PCR (RT_PCR), Multiplexed arrays, and High-density microarrays. Next-generation sequencing dominates the market. The surge in Next-generation sequencing is propelled by the rising occurrence of cancer, the requirement for enhanced accuracy in diagnostics, and the advancement of therapies with specific targets.

The market is divided into twelve categories based on application: Breast, Cervical, Colorectal, Prostate, Lung, Skin, Blood, Liver, Kidney, Ovarian, Pancreatic cancer, and Others. The market is largely influenced by the breast cancer segment, which is propelled by various factors including rising cases of breast cancer, advancements in technology, and a heightened recognition of the significance of early detection.

The market is divided into three categories based on End-users: Hospitals, Ambulatory surgical centers, Diagnostic Laboratories, and Others. Hospitals dominate the market, due to the rising incidence of cancer, increased demand for advanced diagnostic tools, and the growing emphasis on early and precise cancer detection and management.

Advanced Cancer Diagnostics Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The market growth in North America is projected to be dominated by the rapid influx of funding and investments from both governmental and private entities toward cancer diagnosis. Various initiatives have been launched by governments in North America, including the United States and Canada, to support cancer research and diagnostics. Additionally, pharmaceutical companies, diagnostic companies, and venture capital firms are making significant investments in cancer diagnostics and related technologies. These investments are aimed at supporting the development of innovative diagnostic tools and therapies. According to a 2021 study conducted by the International Cancer Research Partnership (ICR Partners), research investment has increased to USD 8.511 billion in 2018. It is important to note that the ICR Partners represent only a small proportion of global cancer funding bodies. Another study identified 4693 organizations that provide cancer research funding, with nearly half classified as not-for-profit organizations and only 12% classified as governmental organizations. Europe and Asia Pacific are expected to drive the growth of the market in the forecast period.

Advanced Cancer Diagnostics Market- Competitive Landscape:

The advanced cancer diagnostics market is characterized by its dynamic nature, driven by continuous technological advancements and evolving healthcare needs. To maintain a competitive position in this rapidly evolving market, companies must prioritize innovation, strategic partnerships, and global expansion. Leading companies in this industry are introducing advanced tests and diagnostics to meet the growing demand for improved diagnostic solutions. Manufacturers specializing in blood cancer diagnostics are focusing on Type launches and implementing new diagnostic methods to optimize their testing processes. Additionally, they are embracing the latest technologies and innovations, ensuring compliance with standard policies to expedite the approval process. The early detection space is populated by numerous key players, ranging from large corporations like Grail, Guardant, and Exact Sciences to promising startups such as Freenome and Singlera. These companies have garnered significant interest and funding due to their groundbreaking announcements and achievements. Notably, their contributions include large-scale studies, versatile machine learning/AI algorithms, pan-cancer detection tests, and substantial funding ranging from hundreds of dollars. Each of these firms possesses unique competitive advantages that set them apart in the market.

Recent Developments:

On 29 June 2022 - The BenchMark ULTRA PLUS structure, Roche's latest sophisticated tissue staining platform, was launched. The system provides rapid and reliable test findings, allowing doctors to make prompt choices about a patient's treatment path.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET KEY PLAYERS

  • Roche Diagnostics
  • Abbott Laboratories
  • Biocept
  • Beckman Coulter Inc
  • Becton Dickinson and Co.
  • Affymetrix Inc
  • Biotheranostics
  • GE Healthcare
  • Gen-Probe Inc
  • Others

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET, BY TYPE

  • Next generation sequencing
  • Lab-on-a-chip
  • Cellular analysis
  • Real-time PCR (RT_PCR)
  • Multiplexed arrays
  • High density microarrays

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET, BY APPLICATION

  • Breast
  • Cervical
  • Colorectal
  • Prostate
  • Lung
  • Skin
  • Blood
  • Liver
  • Kidney
  • Ovarian
  • Pancreatic cancer
  • Others

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET, BY END-USER

  • Hospitals
  • Ambulatory surgical centers
  • Diagnostic Laboratories
  • Others

GLOBAL ADVANCED CANCER DIAGNOSTICS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Advanced Cancer Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Advanced Cancer Diagnostics Market Snippet by Type
    • 2.1.2. Advanced Cancer Diagnostics Market Snippet by Application
    • 2.1.3. Advanced Cancer Diagnostics Market Snippet by End-User
    • 2.1.4. Advanced Cancer Diagnostics Market Snippet by Country
    • 2.1.5. Advanced Cancer Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Advanced Cancer Diagnostics Key Market Trends

  • 3.1. Advanced Cancer Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Advanced Cancer Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Advanced Cancer Diagnostics Market Opportunities
  • 3.4. Advanced Cancer Diagnostics Market Future Trends

4. Advanced Cancer Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Advanced Cancer Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Advanced Cancer Diagnostics Market Landscape

  • 6.1. Advanced Cancer Diagnostics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Advanced Cancer Diagnostics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Next generation sequencing
    • 7.1.3. Lab-on-a-chip
    • 7.1.4. Cellular analysis
    • 7.1.5. Real-time PCR (RT_PCR)
    • 7.1.6. Multiplexed arrays
    • 7.1.7. High density microarrays

8. Advanced Cancer Diagnostics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Breast
    • 8.1.3. Cervical
    • 8.1.4. Colorectal
    • 8.1.5. Prostate
    • 8.1.6. Lung
    • 8.1.7. Skin
    • 8.1.8. Blood
    • 8.1.9. Liver
    • 8.1.10. Kidney
    • 8.1.11. Ovarian
    • 8.1.12. Pancreatic cancer
    • 8.1.13. Others

9. Advanced Cancer Diagnostics Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Ambulatory surgical centers
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Others

10. Advanced Cancer Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Advanced Cancer Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Advanced Cancer Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Advanced Cancer Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Advanced Cancer Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Advanced Cancer Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Advanced Cancer Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Roche Diagnostics
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Biocept
    • 11.2.4. Beckman Coulter Inc
    • 11.2.5. Becton Dickinson and Co.
    • 11.2.6. Affymetrix Inc
    • 11.2.7. Biotheranostics
    • 11.2.8. GE Healthcare
    • 11.2.9. Gen-Probe Inc
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Advanced Cancer Diagnostics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Advanced Cancer Diagnostics Market, by Type 2018-2030 (USD Million)
  • TABLE Advanced Cancer Diagnostics Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Advanced Cancer Diagnostics Market, by Application 2018-2030 (USD Million)
  • TABLE Advanced Cancer Diagnostics Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Advanced Cancer Diagnostics Market, by End-User 2018-2030 (USD Million)
  • TABLE Advanced Cancer Diagnostics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Advanced Cancer Diagnostics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Advanced Cancer Diagnostics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Advanced Cancer Diagnostics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Advanced Cancer Diagnostics Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Advanced Cancer Diagnostics Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Advanced Cancer Diagnostics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022 & 2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE Europe Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE Asia Pacific Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE Latin America Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE Middle East and Africa Advanced Cancer Diagnostics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Advanced Cancer Diagnostics Market share analysis by country, 2022
  • FIGURE Germany Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Advanced Cancer Diagnostics Market share analysis by country, 2022
  • FIGURE India Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Advanced Cancer Diagnostics Market share analysis by country, 2022
  • FIGURE Brazil Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Advanced Cancer Diagnostics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Advanced Cancer Diagnostics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)